SCHEMBL7581124

SCHEMBL7581124

Cc1ccc(Cl)c(C(=O)c2ccc(Cl)cc2)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.47
MAPK1 P28482 1/20 0.47
HPGD P15428 1/20 0.46
CES2 O00748 2/20 0.46
CES1 P23141 2/20 0.46
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
HTT P42858 3/20 0.41
LMNA P02545 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
NR4A1 P22736 1/20 0.41
PTGS2 P35354 2/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7581152 0.85 ALDH1A1 (0.46) SRD5A2MAPK1CES2CES1LMNA
SCHEMBL30692010 0.77 SRD5A2 (0.50) SRD5A2MAPK1HPGDCES2CES1
SCHEMBL19882311 0.76 ALDH1A1 (0.44) MAPK1HPGDTSHRHTTLMNA
SCHEMBL11216806 0.76 DPP4 (0.54) MAPK1TSHRLMNANR4A1PTGS2
SCHEMBL15100942 0.76 SRD5A2 (0.53) SRD5A2MAPK1HPGDCES2CES1
SCHEMBL9712488 0.75 SRD5A2 (0.44) SRD5A2MAPK1HPGDCES2CES1
SCHEMBL4640149 0.75 CLCN2 (0.47) MAPK1TSHRLMNACYP1A2MAPT
SCHEMBL7273972 0.75 SRD5A2 (0.52) SRD5A2MAPK1HPGDCES2CES1
SCHEMBL11850279 0.74 SRD5A2 (0.56) SRD5A2MAPK1HPGDCES2CES1
SCHEMBL1315648 0.74 RAB9A (0.43) SRD5A2MAPK1HPGDCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0810218-B1 6-Benzyl-2H-pyridazin-3-one derivatives,their preparation and their use as inhibitors of prostaglandin G/H synthase I and II (COX I and COX II) HOFFMANN LA ROCHE (CH) 2002-12-04 EP disclosed
US-5886178-A ADMINISTERING OF A PROSTAGLANDIN G/H SYNTHASE INHIBITOR TO A PATIENT TO TREAT INFLAMMATORY OR AUTOIMMUNE DISEASES SYNTEX (U.S.A.) INC. (US) 1999-03-23 US disclosed
EP-0810218-A1 6-Benzyl-2H-pyridazin-3-one derivatives,their preparation and their use as inhibitors of prostaglandin G/H synthase I and II (COX I and COX II) F. HOFFMANN-LA ROCHE AG (CH) 1997-12-03 EP disclosed